InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-63.5%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Meline David W, Chief Financial Officer. Director active across 3 companies, notably Moderna, Inc.. Cumulatively, 7 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €162k. History available since 9 February 2022. The latest transaction was filed on 18 June 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Meline David W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
17,116 shares0Common StockSEC:0001299130-24-000151:0
7,943 shares0Common StockSEC:0000950172-24-000228:0
40,000 shares@ US$4.404100.0% of flowCommon StockSEC:0001299130-24-000076:0
Canonical exit: 4 Jun 2024 (T+90)
2,747 shares0Common StockSEC:0001209191-23-054388:0
348 shares0Common StockSEC:0001127602-22-020829:0
348 shares@ US$134.40100.0% of flowCommon StockSEC:0001127602-22-014148:0
1,392 shares0Common StockSEC:0001127602-22-004566:0
7 of 7 declarations
About Meline David W
Meline David W is Directeur Financier and also serves as Chief Financial Officer at Moderna, Inc., as Director at Pacific Biosciences of California, INC., and as Director at HP INC. Across 7 filings in total, the 7 sampled filings run from 2022-02-11 to 2024-06-20, with EUR 162270 of buys and EUR 0 of sells, and the most frequent transaction nature is Attribution.
